IRWD
IRWD
NASDAQ · Biotechnology

Ironwood Pharmaceuticals Inc

$3.04
-0.19 (-5.88%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +1,600.7% upside
Low Target $40.79
Average Target $51.70
High Target $62.56
Current Price $3.04
Current
$3.04
Target
$51.70
$40.79 $51.70 avg $62.56
Scenario Analysis
Bear Case
$40.79
1,241.8%
Low target
Base Case
$51.70
+1,600.7%
Avg target
Bull Case
$62.56
+1,957.9%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$5.78
-47.4% from high
52-Week Low
$0.53
+476.7% from low
Target vs 52W High
$51.70
+794.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%